Exercise-induced bronchoconstriction

Diagnosis and management

Michael A. Krafczyk, Chad A. Asplund

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Exercise-induced bronchoconstriction describes the narrowing of the airway that occurs with exercise. More than 10 percent of the general population and up to 90 percent of persons previously diagnosed with asthma have exercise-induced bronchoconstriction. Common symptoms include coughing, wheezing, and chest tightness with exercise; however, many athletes will present with nonspecific symptoms, such as fatigue and impaired performance. Spirometry should be performed initially to evaluate for underlying chronic asthma, although results are often normal. An empiric trial of short-acting beta2 agonists or additional bronchial provocation testing may be necessary to confirm the diagnosis. Nonpharmacologic treatment options include avoiding known triggers, choosing sports with low minute ventilation, warming up before exercising, and wearing a heat exchange mask in cold weather. Short-acting beta2 agonists are recommended first-line agents for pharmacologic treatment, although leukotriene receptor antagonists or inhaled corticosteroids with or without long-acting beta2 agonists may be needed in refractory cases. If symptoms persist despite treatment, alternative diagnoses such as cardiac or other pulmonary etiologies, vocal cord dysfunction, or anxiety should be considered.

Original languageEnglish (US)
Pages (from-to)427-434
Number of pages8
JournalAmerican Family Physician
Volume84
Issue number4
StatePublished - Jan 1 2011

Fingerprint

Bronchoconstriction
Exercise
Vocal Cord Dysfunction
Exercise-Induced Asthma
Leukotriene Antagonists
Spirometry
Respiratory Sounds
Weather
Masks
Athletes
Sports
Fatigue
Ventilation
Adrenal Cortex Hormones
Thorax
Therapeutics
Asthma
Anxiety
Hot Temperature
Lung

ASJC Scopus subject areas

  • Family Practice

Cite this

Krafczyk, M. A., & Asplund, C. A. (2011). Exercise-induced bronchoconstriction: Diagnosis and management. American Family Physician, 84(4), 427-434.

Exercise-induced bronchoconstriction : Diagnosis and management. / Krafczyk, Michael A.; Asplund, Chad A.

In: American Family Physician, Vol. 84, No. 4, 01.01.2011, p. 427-434.

Research output: Contribution to journalArticle

Krafczyk, MA & Asplund, CA 2011, 'Exercise-induced bronchoconstriction: Diagnosis and management', American Family Physician, vol. 84, no. 4, pp. 427-434.
Krafczyk, Michael A. ; Asplund, Chad A. / Exercise-induced bronchoconstriction : Diagnosis and management. In: American Family Physician. 2011 ; Vol. 84, No. 4. pp. 427-434.
@article{2cc9e7058acd4c9fa420e3a3b16a9f9b,
title = "Exercise-induced bronchoconstriction: Diagnosis and management",
abstract = "Exercise-induced bronchoconstriction describes the narrowing of the airway that occurs with exercise. More than 10 percent of the general population and up to 90 percent of persons previously diagnosed with asthma have exercise-induced bronchoconstriction. Common symptoms include coughing, wheezing, and chest tightness with exercise; however, many athletes will present with nonspecific symptoms, such as fatigue and impaired performance. Spirometry should be performed initially to evaluate for underlying chronic asthma, although results are often normal. An empiric trial of short-acting beta2 agonists or additional bronchial provocation testing may be necessary to confirm the diagnosis. Nonpharmacologic treatment options include avoiding known triggers, choosing sports with low minute ventilation, warming up before exercising, and wearing a heat exchange mask in cold weather. Short-acting beta2 agonists are recommended first-line agents for pharmacologic treatment, although leukotriene receptor antagonists or inhaled corticosteroids with or without long-acting beta2 agonists may be needed in refractory cases. If symptoms persist despite treatment, alternative diagnoses such as cardiac or other pulmonary etiologies, vocal cord dysfunction, or anxiety should be considered.",
author = "Krafczyk, {Michael A.} and Asplund, {Chad A.}",
year = "2011",
month = "1",
day = "1",
language = "English (US)",
volume = "84",
pages = "427--434",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "4",

}

TY - JOUR

T1 - Exercise-induced bronchoconstriction

T2 - Diagnosis and management

AU - Krafczyk, Michael A.

AU - Asplund, Chad A.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Exercise-induced bronchoconstriction describes the narrowing of the airway that occurs with exercise. More than 10 percent of the general population and up to 90 percent of persons previously diagnosed with asthma have exercise-induced bronchoconstriction. Common symptoms include coughing, wheezing, and chest tightness with exercise; however, many athletes will present with nonspecific symptoms, such as fatigue and impaired performance. Spirometry should be performed initially to evaluate for underlying chronic asthma, although results are often normal. An empiric trial of short-acting beta2 agonists or additional bronchial provocation testing may be necessary to confirm the diagnosis. Nonpharmacologic treatment options include avoiding known triggers, choosing sports with low minute ventilation, warming up before exercising, and wearing a heat exchange mask in cold weather. Short-acting beta2 agonists are recommended first-line agents for pharmacologic treatment, although leukotriene receptor antagonists or inhaled corticosteroids with or without long-acting beta2 agonists may be needed in refractory cases. If symptoms persist despite treatment, alternative diagnoses such as cardiac or other pulmonary etiologies, vocal cord dysfunction, or anxiety should be considered.

AB - Exercise-induced bronchoconstriction describes the narrowing of the airway that occurs with exercise. More than 10 percent of the general population and up to 90 percent of persons previously diagnosed with asthma have exercise-induced bronchoconstriction. Common symptoms include coughing, wheezing, and chest tightness with exercise; however, many athletes will present with nonspecific symptoms, such as fatigue and impaired performance. Spirometry should be performed initially to evaluate for underlying chronic asthma, although results are often normal. An empiric trial of short-acting beta2 agonists or additional bronchial provocation testing may be necessary to confirm the diagnosis. Nonpharmacologic treatment options include avoiding known triggers, choosing sports with low minute ventilation, warming up before exercising, and wearing a heat exchange mask in cold weather. Short-acting beta2 agonists are recommended first-line agents for pharmacologic treatment, although leukotriene receptor antagonists or inhaled corticosteroids with or without long-acting beta2 agonists may be needed in refractory cases. If symptoms persist despite treatment, alternative diagnoses such as cardiac or other pulmonary etiologies, vocal cord dysfunction, or anxiety should be considered.

UR - http://www.scopus.com/inward/record.url?scp=80051710002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051710002&partnerID=8YFLogxK

M3 - Article

VL - 84

SP - 427

EP - 434

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 4

ER -